Many of the trials delivered at the CRF are run in collaboration with commercial companies who are developing new treatments or testing new devices. Some of these trials are co-funded by medical research charities and by the Government.
We collaborate with some of the world’s largest pharmaceutical companies, such as AstraZeneca, GlaxoSmithKline and Roche and also work with specialist small to medium-sized enterprises (SMEs), such as E-therapeutics, Oncolytics and Transgene.
The patient pool we can recruit from is extensive. Leeds Teaching Hospitals is one of the largest NHS Trusts in the country, providing specialist care for up to 5.4 million people in Yorkshire and Humberside, drawn from a region that is ethnically and geographically diverse.
The strong partnership between Leeds Teaching Hospitals and the University of Leeds jointly represents a vast wealth of resources - financial, infrastructure, people and methodologies – that companies working with us can draw on. This spans the entire medical pipeline from discovery science through to widespread and routine implementation at patient and practitioner level. The clinical and academic resources underpinning our facility ensures we provide an exceptionally high quality of data from our trials. Additional expertise we draw on includes the Leeds Clinical Trials Research Unit, the Haematological Malignancies Diagnostics Service, the Leeds Biobanking and Sample Processing Facility and phenotyping expertise within the NIHR Leeds Musculoskeletal Biomedical Research Unit.
To talk to us about running your trial at NIHR Leeds CRF, contact:
Dr Chris McKee, Research & Innovation Manager for Performance & Industry, Leeds Teaching Hospitals
Tel 0113 2060494
Dr Chris McKee’s role as the Business Development and Innovation Manager based in Leeds is to support the Leeds Teaching Hospital Trust (LTHT) in Research and Innovation, support both Leeds NIHR Medtech In Vitro Diagnostic Cooperatives, and support the University of Leeds to identify and engage with innovative medical/health technologies for future collaborations and NHS evaluations in areas of unmet clinical needs.
Further to this he also works closely with the Yorkshire & Humber Academic Health Science Network supporting their interests at a national level. This role involves engaging small to medium enterprises and larger corporates both nationally and internationally in order to establish future relationships and collaborations based in the Leeds City Region and wider AHSN networks working towards the joint benefit of industry partners, academics and the LTHT.
Dr McKee will be providing support to the LCRF programme bringing all the aforementioned networks to the table of opportunities that are available when working with LCRF.